Profile
ABOS VRTX VRNA REGN ALNY ARGX
Company Name Acumen Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Verona Pharma plc Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $136.90M $108.04B $72.68B $68.01B $60.75B $50.28B
Employees 0.06K 6.10K 0.21K 15.16K 2.23K 1.60K
CEO Daniel J. O'Connell Reshma Kewalramani FASN, David S. Zaccardelli Leonard S. Schleifer Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
ABOS VRTX VRNA REGN ALNY ARGX
Quant Rating Score 2 3 1 4 1 3
Quant Rating Sell Neutral Strong Sell Buy Strong Sell Neutral
Trading
ABOS VRTX VRNA REGN ALNY ARGX
Last Close $2.26 $417.21 $106.91 $652.91 $481.59 $821.97
High 52 $3.27 $516.74 $106.91 $922.79 $491.09 $849.46
Low 52 $0.9 $366.54 $33.93 $482.92 $224.58 $532.27
Price vs. 52 Week High -30.89 % -19.26 % 0 % -29.25 % -1.93 % -3.24 %
Price vs. 52 Week Low 151.11 % 13.82 % 215.09 % 35.2 % 114.44 % 54.43 %
Total Return
ABOS VRTX VRNA REGN ALNY ARGX
1 Month Return 32.16 % 6.53 % 0.17 % 16.12 % 5.63 % 11.42 %
3 Month Return 54.79 % -11.07 % 1.68 % 17.71 % 41.85 % 37.25 %
6 Month Return 100 % -18.11 % 48.2 % 9.05 % 82.89 % 27.56 %
9 Month Return 44.87 % -4.83 % 86.77 % -4.42 % 73.76 % 23.48 %
YTD Return 31.4 % 3.6 % 130.21 % -8.34 % 104.66 % 33.65 %
1 Year Return -25.41 % -12.18 % 212.69 % -29.25 % 71.09 % 48.99 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABOS VRTX VRNA REGN ALNY ARGX
Dividend Yield Percentage (TTM) - - - 0.4 % - -
Dividend Paid and Capex Coverage Ration (TTM) -1338.23 % 11.09 % -147.93 % 4.25 % -0.43 % 65.28 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 6.06 % - -
Growth
ABOS VRTX VRNA REGN ALNY ARGX
Asset Growth -22.94 % -0.87 %
Gross Profit Growth 99.58 % 10.25 %
Revenue Growth - 11.66 %
Revenue 3 Year - 45.6 %
Revenue 5 Year -100 % 163.93 %
Revenue 10 Year -100 % 1632.15 %
EBIT Growth -89.73 % -93.69 %
Net Income Growth -95.39 % -114.8 %
Net Income 3 Yeari Growth Per Share 35.14 % -122.89 %
Net Income 5 Yeari Growth Per Share -517.86 % -145.38 %
Net Income 10 Yeari Growth Per Share -517.86 % 33.84 %
Operating Income Growth -86.49 % -106.08 %
Operating Cash Flow Growth (CFG) -100.2 % -113.93 %
Operating 3 Year CFG -206.07 % -118.65 %
Operating 5 Year CFG -503.71 % -131.3 %
Operating 10 Year CFG -503.71 % 12.43 %
EPS Growth -58.33 % -114.8 %
EPS Diluted Growth -58.33 % -114.97 %
Book Value Per Share -44.97 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -48.52 % 62.6 %
Share Holder 5 Year Equity Growth Per Share 860.1 % 168.85 %
Share Holder 10 Year Equity Growth Per Share 860.1 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -4.33 % 116.42 %
Free Cash Flow Growth -100.14 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
ABOS VRTX VRNA REGN ALNY ARGX
Gross Profit Margin TTM -0.56 % 86.11 % 95.15 % 85.39 % 83.64 % 65.82 %
Return on Assets TTM -79.5 % 15.13 % -14.17 % 11.4 % -6.99 % 15.06 %
Return on Equity TTM -81.39 % 22.14 % -38.66 % 15.31 % -274.21 % 18.96 %
Return on Capital Employed TTM -97.92 % 19.72 % -10.74 % 10.32 % -5.52 % 5.04 %
Net Income Per EBT TTM 100 % 83.16 % 111.3 % 88.98 % 84.06 % 237.3 %
EBT Per Ebit TTM 94.92 % 111.48 % 130.22 % 139.5 % 210.66 % 147.38 %
EBIT Per Revenue TTM -80888.76 % 34.36 % -25.27 % 25.89 % -7.32 % 13.47 %
Cash Flow To Debt Ratio TTM -394.1 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Receivables Turnover TTM - 6.03 2.55 2.51 4.34 1.91
Payables Turnover TTM 0.09 3.59 3.13 2.3 3.93 0.9
Inventory Turnover TTM - 1.06 1.25 0.64 5.62 2.26
Fixed Asset Turnover TTM - 431.08 % 8642.22 % 284.82 % 355.68 % 5009.77 %
Asset Turnover TTM 0.1 % 47.51 % 38.7 % 35.47 % 53.92 % 31.97 %
Operating Cash Flow Per Share TTM -1.94 14.98 -0.85 48.94 -0.12 5.67
Free Cash Flow Per Share TTM -1.95 13.63 -0.85 40.09 -0.4 5.58
Cash Per Share TTM 236.69 % 2486.48 % 511.44 % 8148.65 % 2203.63 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -66159.55 % 33.68 % -32.7 % 35.59 % -0.63 % 17.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.07 % 90.99 % 100.75 % 81.92 % 335.21 % 98.47 %
Cash Flow Coverage Ratios TTM -394.1 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Price To Free Cash Flows Ratio TTM -1.16 30.87 -995.27 16.37 -1166.22 132.81
Price To Operating Cash Flows Ratio TTM -1.16 28.12 -126.33 13.34 -3867.41 151.69
Price Cash Flow Ratio TTM -1.16 28.12 -126.33 13.34 -3867.41 151.69
Income Statement (TTM)
ABOS VRTX VRNA REGN ALNY ARGX
Revenue $0B $11.02B $0.03B $14.2B $2.25B $2.19B
Gross Profit $-0B $9.49B $0.03B $12.23B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 93.89% 86.13% 85.62% 89.62%
EBITDA $-0.1B $0.49B $-0.12B $5.32B $-0.18B $0.11B
Net Income $-0.1B $-0.54B $-0.14B $4.41B $-0.28B $0.83B
EPS Diluted -1.71 -2.08 -1.73 38.34 -2.18 12.78
Balance Sheet (MRQ)
ABOS VRTX VRNA REGN ALNY ARGX
Long Term Debt $0.03B $1.66B $0.12B $2.7B $1.25B $0.03B
Total Liabilities $0.06B $6.12B $0.27B $8.41B $4.17B $0.7B
Total Equity $0.18B $16.41B $0.2B $29.35B $0.07B $5.5B
Total Investments $0.2B $6.65B $0.02B $15.42B $1.73B $1.93B
Total Debt $0.03B $1.75B $0.12B $2.7B $1.3B $0.04B
Total Assets $0.24B $22.53B $0.47B $37.76B $4.24B $6.2B
Cash Flow Statement (TTM)
ABOS VRTX VRNA REGN ALNY ARGX
Net Income $-0.1B $-0.54B $-0.17B $4.41B $-0.28B $0.83B
Inventory $0B $-0.52B $-0.01B $-0.62B $0.01B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.09B $-0.49B $-0.12B $4.42B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0B $-0.76B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 33.7999
AARD Aardvark Therapeutics, Inc. Common Stock 11.1293
ABCL AbCellera Biologics Inc. 5.445
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.205
ABIO ARCA biopharma, Inc. 28.8
ABPWW 0.0143
ABSI Absci Corporation 4.2312
ABUS Arbutus Biopharma Corporation 4.875
ABVC ABVC BioPharma, Inc. 2.84
ABVX Abivax SA American Depositary Shares 104.808
ACAD ACADIA Pharmaceuticals Inc. 22.6
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7774
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 5.195
ACIU AC Immune SA 3.465
ACLX Arcellx, Inc. 87.93
ETFs With Exposure to ABOS
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00016 246.7
VTI Vanguard Total Stock Market Index Fund 0.00009 336.35
IBB iShares Biotechnology ETF 0.01258 157.93
IWN iShares Russell 2000 Value ETF 0.00035 177.87
BIB ProShares Ultra Nasdaq Biotechnology 0.00535472 70.41
VXF Vanguard Extended Market Index Fund 0.00065 211.255
HDG ProShares Hedge Replication ETF 0.000269689 51.7342
UWM ProShares Ultra Russell2000 0.00157102 47.8
VTHR Vanguard Russell 3000 Index Fund 0 301.6
IWC iShares Micro-Cap ETF 0.01797 156.28
URTY ProShares UltraPro Russell2000 0.00125687 55.045
VTWV Vanguard Russell 2000 Value Index Fund 0.00373 156.68
CSML IQ Chaikin U.S. Small Cap ETF 0.17 34.9484
VTWO Vanguard Russell 2000 Index Fund 0.00168 99.74
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 47.03
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00017 114.81
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00017 114.79
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00007 53.54
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00007 53.53
VBINX Vanguard Balanced Index Fund Investor Shares 0.00007 53.53
BMED BlackRock Future Health ETF 0.03 28.4454
DFAU Dimensional US Core Equity Market ETF 0.00048189 46.795
IBBQ Invesco Nasdaq Biotechnology ETF 0.017 26.51
DFAT Dimensional U.S. Targeted Value ETF 0.00000769 57.205
DFAS Dimensional U.S. Small Cap ETF 0.0001142 68.1979
DFAC Dimensional U.S. Core Equity 2 ETF 0.00002324 39.165
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.03546 6.711
VTSAX Vanguard Total Stock Market Index Fund 0.00009 164.31
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01585 7.745
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00065 160.9
VITSX Vanguard Total Stock Market Index Fund 0.00009 164.34
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.01585 7.724
IBRN iShares Neuroscience and Healthcare ETF 0.17376 30.32
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000123949 16.65
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00065 160.91
AVSC Avantis U.S. Small Cap Equity ETF 0 57.505
VTS.AX Vanguard US Total Market Shares Index ETF 0.00008 512.34
DCOR Dimensional ETF Trust 0.00005219 73.105
VEMPX Vanguard Extended Market Index InstlPlus 0.00065 397.07
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00009 308.28
RSSL Global X Funds 0 96.825
DXUV Dimensional ETF Trust 0.0000186 58.8592
Unlock